Huayun Feng

机构：Shanxi Medical University · ORCID：0000-0003-1821-2979

发表论文 9 篇 · 总被引 128 次 · h-index 6

代表论文

• Design, synthesis, SAR discussion, in vitro and in vivo evaluation of novel selective EGFR modulator to inhibit L858R/T790M double mutants (2017 · European Journal of Medicinal Chemistry · 被引 38)
• Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer (2018 · Organic & Biomolecular Chemistry · 被引 33)
• 3D-QSAR-aided design, synthesis, in vitro and in vivo evaluation of dipeptidyl boronic acid proteasome inhibitors and mechanism studies (2016 · Bioorganic & Medicinal Chemistry · 被引 17)
• Design, synthesis and docking studies of novel dipeptidyl boronic acid proteasome inhibitors constructed from αα- and αβ-amino acids (2016 · Bioorganic & Medicinal Chemistry Letters · 被引 13)
• Design, synthesis, in vitro and in vivo evaluation, and structure-activity relationship (SAR) discussion of novel dipeptidyl boronic acid proteasome inhibitors as orally available anti-cancer agents for the treatment of multiple myeloma and mechanism studies (2018 · Bioorganic & Medicinal Chemistry · 被引 12)
• Preparation and biological evaluation of soluble tetrapeptide epoxyketone proteasome inhibitors (2019 · Bioorganic & Medicinal Chemistry · 被引 6)